Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
BioInno logo — Empowering global biopharma with world-class cell culture an...

BioInno

Empowering global biopharma with world-class cell culture and GMP production services.

Founded 2019 Series A Biopharma, Biotechnology +1

General Information

Company Name BioInno
Founded Year 2019
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series A
Social

Get notified when BioInno moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BioInno

BioInno is a China-based startup that aims to empower global biopharma with world-class cell culture and GMP production services. Established in 2019, BioInno offers comprehensive biopharmaceutical CDMO services and cell culture media, specializing in process development and GMP production. The company is focused on supporting businesses in bringing protein, cell therapy, and gene therapy drugs to both Chinese and global markets. In its latest milestone, BioInno secured a Series A investment on 21st December 2021. The investment was led by a consortium of investors including EFung Capital, 深圳市道合科技投资管理有限公司, Yuanqi Capital, Guoxin Investment, Yifeng Capital, Tigermed, and TaiKun Fund. With its expertise in the Biopharma, Biotechnology, and Pharmaceutical industries, BioInno stands poised to make a significant impact in the global biopharmaceutical landscape.

Taxonomy: Biopharma, CDMO services, Cell culture, GMP production, Process development, Protein drugs, Cell therapy, Gene therapy, China-based, Global market, Biopharmaceutical supplier, Cell culture media, GMP, Pharmaceutical production, Drug development

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 7
Investor Investor Investor Investor
•••• •••• 		21 Dec 2021

BioInno Alternatives & Competitors

BioInno vs
Cell Matters
Cell Matters

Enhancing cell therapy productivity with advanced cryopreservation solutions and GMP-compliant servi...

Series A
Biotechnology, Health and Wellness
BioInno vs
Cell Culture Company
Cell Culture Company United States

Rx, Dx, Genomic, Animal Health Support: Cell Banking, Cell Culture, Purification, Process Dev, Analy...

18 employees
Biotechnology
BioInno vs
PL BioScience GmbH
PL BioScience GmbH Germany

Innovating Cell Culture since 2015, xeno-free | Experts in Human Platelet Lysate | Home of the ELARE...

Series A
34 employees
Biotechnology, Health Care

FAQ About BioInno

Empowering global biopharma with world-class cell culture and GMP production services.
BioInno was founded in 2019.
BioInno operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
BioInno has completed 1 funding round. The latest funding stage is Series A.
Top alternatives and competitors to BioInno include Cell Matters, Cell Culture Company, PL BioScience GmbH, Wilson Wolf Manufacturing, LLC, cart medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioInno and Cell Matters are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BioInno and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy